<DOC>
	<DOCNO>NCT02099006</DOCNO>
	<brief_summary>This study test drug previously use topically treatment vulvodynia , common genital pain syndrome . It hop one drug improve vaginal entryway pain touch , daily pain score sexual functioning .</brief_summary>
	<brief_title>Novel Topical Therapies Treatment Genital Pain</brief_title>
	<detailed_description>Vulvodynia define burn pain , occur absence visible find clinically identifiable nervous disorder . Current treatment include vulvar care measure , topical medication , oral medication , biofeedback , physical therapy surgery . The usual treatment patient take either tricyclic antidepressant anti convulsants orally , however method seldom bring total relief . These drug significant side effect limit patient 's tolerance high sometimes need . An effective topical medication would greatly benefit woman few side effect well tolerance . Topical amitriptyline baclofen often prescribe , study do support use . Topical gabapentin also show good effect , prospective clinical study do . This study test topical application Cetaphil , Loperamide , Gabapentin , Ketoprofen , Ketamine Amitriptyline 19 week period first phase study . The drug compound University Rochester research pharmacy dispense 19 vial , one vial use week . Patients study personnel blind drug use . Each study participant give week placebo initiation study . Each study compound , contain drug base ( Cetaphil ) use twice day two week row , follow one week washout base alone . If patient find one drug effective may stop participation first 13 week request effective drug prescribe . The unblinding officer would work research pharmacy identify effective drug provide patient prescription drug . If patient desire , may enroll second phase study test last two drug six week period washout first segment study . The drug would administer vial first section study . Every week Sunday patient complete electronic diary , record daily pain , drug side effect , pain tampon test overall health . Every three week complete Female Sexual Function Index electronic system . She would start new drug Monday week . Additionally coordinator study call patient Wednesday see problem drug start Monday . All patient could become pregnant require maintain effective contraception throughout study .</detailed_description>
	<mesh_term>Genital Diseases , Female</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>Amitriptyline , perphenazine drug combination</mesh_term>
	<mesh_term>Loperamide</mesh_term>
	<criteria>Women age 18 65 complain localize provoke vulvar pain meet criterion diagnosis localize provoked vulvodynia . Patients fail unable tolerate previous attempt systematic therapy surgery specifically recruit . 1 . The presence dermatologic neurologic condition determine investigator primary cause patient 's pain . 2 . Allergy medication base . 3 . Concurrent use follow medication . . The patient may enroll study two week washout medication . Patients may need receive approval prescribe physician stopping medication . Failure obtain approval medication cessation would cause exclusion . Gabapentin ( NeurontinTM ) Amitriptyline ( ElavilTM ) Nortriptyline ( PamelorTM ) Desipramine ( NorpraminTM ) Tramadol ( UltramTM , ConZipTM , RybixTM , RysoltTM , Ultram ERTM ) Pregabalin ( LyricaTM ) Baclofen</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>